Advisers & FriendsDavid P. Richman, M.D.
|
Clinical/Research InterestsDavid P. Richman's professional interests include biochemistry and pharmacology of the nicotinic acetylcholine receptor, diseases of neuromuscular transmission, and pathogenesis and control of autoimmune response in myasthenia gravis. Richman has coauthor an extensive list of publications and book chapters on neurological disease and related topics. His research activities have focused on myasthenia, myasthenia gravis and multiple sclerosis. |
Title: |
Professor Director of Residency Program |
Specialty: |
Neurology |
Address: |
Lawrence J. Ellison Ambulatory Care Center 4860 Y St., Suite 0100 Sacramento, CA 95817 |
Phone: |
(916) 734-3588 |
Education: |
Johns Hopkins University School of Medicine Baltimore, Maryland M.D. 1969 |
|
Princeton University Princeton, New Jersey A.B. 1965 |
|
Internships: |
Albert Einstein College of Medicine New York City, New York 1969-70 Medicine |
Residency: |
Massachusetts General Hospital Boston, Massachusetts 1973-74 Neurology Albert Einstein College of Medicine New York City, New York 1970-71 Neurology |
Fellowships: |
Massachusetts General Hospital Boston , Massachusetts 1974-76 Neurology Harvard Medical School Boston, Massachusetts 1974-75 Neurology |
Board Certifications: |
American Board of Psychiatry and Neurology, 1976 |
Professional Memberships: |
American Academy of Family Physicians American Academy of Neurology American Association for the Advancement of Science American Association of Immunologists American Neurological Association National Myasthenia Gravis Foundation, Inc. |
Select Recent Publications: |
Agius, M.A., Richman, D.P., and Vincent, A. Specific antibodies in the diagnosis and management of autoimmune disorders of neuromuscular transmission and related diseases. In Myasthenia Gravis and Related Disorders. H.J. Kaminski (Ed.). Humana Press: Totowa, New Jersey, pp.177-196, 2002. Maselli, R.A., Kong, D., Bowe, C., McDonald, C., Ellis, W., Agius, M.A., Gomez, C.M., Richman, D.P., and Wollmann, R.L. Presynaptic congenital myasthenic syndrome due to quantal release deficiency. Neurology 57: 279-289, 2001. Richman, D.P. Thymectomy in myasthenia gravis: Problems and questions remain. Editorial. Journal Watch Neurology 3: 4, 2001. Roberts, P.F., Venuta, F., Rendina, E., De Giancomo, T., Coloni, G.F., Follette, D.M., Richman, D.P. and Benfield, J.R. Thymectomy in the treatment of ocular myasthenia gravis. J. Thor. Cardiovasc. Surg. 122: 562-8, 2001. Fairclough, R.H., Twaddle, G.M., Gudipati, E., Richman, D.P., Burkwall, D.A., and Josephs R. Mapping the mAb 383C epitope to a2(187-199) of the Torpedo acetylcholine receptor on the three dimensional model. J. Mol. Biol. 282:301-315, 1998. Fairclough, R.H., Twaddle, G.M., Gudipati, E., Lin, M.Y. and Richman, D.P. Differential surface accessibility of a(187-199) in the Torpedo acetylcholine receptor a subunits. J. Mol. Biol. 282:317-330, 1998. Lin MY, Twaddle GM, Gudipati E, Richman DP, Fairclough RH. mAb 383C binds to the (-subunit of the AChR associated with the high affinity tubocurarine site. Annals of New York Academy of Science 1998;841: 101-103 Fairclough RH, Gupidati E, Lin MY, Twaddle GM, Richman DP,Burkwall DA, Josephs R. A role for ((187-199)) in the conversion of agonist binding energy to the opening of the AChR receptor ion channel. Annals of New York Academy of Science 1998;841: 87-93 Kirvan CA, Zhu S, Richman DP, Agius MA. Expression and initial characterization of recombinant/hybrid anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis. Annals of New York Academy of Science 1998;841: 466-468 Richman DP, Agius MA, Kirvan CA, Gomez CM, Fairclough RH, DuPont BL, Maselli RA. Antibody effector mechanisms in myasthenia gravis: the complement hypothesis Annals of New York Academy of Science 1998;841: 450-465 |
To see if David P. Richman is accepting new patients, or for assistance finding a UC Davis doctor, please call (800) 2-UC DAVIS.